Partnership brings the proprietary technology behind Click’s FDA-authorized digital migraine intervention to the Ultrahuman ...
Ultrahuman, a leader in wearable health technology, announced in January 2026 a partnership with Click Therapeutics to ...
ESPOO, Finland, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Adalyon, a pioneering tech-bio company using its AI-powered speech biomarker platform to transform clinical drug development, today announced the ...
A quantitative screening assay will be developed based on Courtagen’s protein biomarker platform. Courtagen Life Sciences inked a deal with Avaxia Biologics to develop an assay that can streamline the ...
CHICAGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking, the world’s first ecosystem for memory and thinking concerns announced today that they have entered into an exclusive agreement to use ...
BOSTON--(BUSINESS WIRE)--As consumer intrigue and demand for accessible health wearables grows, the convergence of voice artificial intelligence (AI) and proactive health tools is setting the standard ...
RCE Technologies, Inc. (RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. RCE Technologies Inc. has announced ...
MEDiC Life Sciences Secures $5M in Strategic Investments from LG and Hanmi to Drive the Adoption of Its Innovative Cancer Biomarker Discovery Technology MEDiC Life Sciences ("MEDiC"), a leading ...
WASHINGTON, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay ...